This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Boswellia serrata
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
This herb may interact with medications you are taking. Review the interactions table below and consult your healthcare provider before use.
Boswellia is a tree resin (frankincense) that has been used in Ayurvedic medicine for over 3,000 years for inflammatory and arthritic conditions. Its primary active compounds, boswellic acids, are unique 5-lipoxygenase inhibitors. Clinical trials support its use for osteoarthritis, inflammatory bowel disease, and asthma.
Boswellia is a tree resin (frankincense) that has been used in Ayurvedic medicine for over 3,000 years for inflammatory and arthritic conditions. Its primary active compounds, boswellic acids, are unique 5-lipoxygenase inhibitors. Clinical trials support its use for osteoarthritis, inflammatory bowel disease, and asthma. Key active compounds include Acetyl-11-keto-beta-boswellic acid (AKBA), Beta-boswellic acid, Incensole.
Acetyl-11-keto-beta-boswellic acid (AKBA), along with Beta-boswellic acid and Incensole, are the primary bioactive compounds in Boswellia. These compounds modulates NF-κB and COX-2 inflammatory pathways.
Osteoarthritis
Supported by clinical evidence; more large-scale trials would strengthen findings
Rheumatoid arthritis
Supported by clinical evidence; more large-scale trials would strengthen findings
Inflammatory bowel disease
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Asthma
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Tendonitis and joint inflammation
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Joint pain relief
Based on traditional use; clinical evidence limited
Respiratory support
Based on traditional use; clinical evidence limited
Digestive anti-inflammatory
Based on traditional use; clinical evidence limited
| Drug | Severity | Description |
|---|---|---|
| Ibuprofen and NSAIDs | Mild | Boswellia may have additive anti-inflammatory effects with NSAIDs, potentially allowing NSAID dose reduction. |
| Warfarin (Coumadin) | Moderate | Boswellia may have mild antiplatelet effects that increase bleeding risk with warfarin. |
Found an error or have a correction for Boswellia?
Report an Issue →